Updated hourlyHourly refreshSat, Jul 25, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telefonaktiebolaget LM Ericsson ("Ericsson" or "the Company") (NASDAQ:ERIC). Investors who purchased Ericsson securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/ERIC. Ericsson Investigation Details On July 14, 2026, Ericsson reported Q2 2026 results that missed Wall Street estimates for both revenue and adjusted EPS. Ericsson reported Q2 net sales of SEK 52.7 billion (approximately $5.43 billion), below analyst expectations of approximately $5.68 billion, and adjusted EPS of $0.1258, compared ..
Jul 24 · 15:02·PR-Inside
Finance · AI
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alphabet Inc. ("Alphabet" or "the Company") (NASDAQ:GOOG). Investors who purchased Alphabet securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/GOOG. Alphabet Investigation Details On July 16, 2026, Bloomberg news reported that Alphabet's Google is "months behind schedule on delivering Gemini 3.5 Pro, its most powerful flagship AI model" due to the Company's ongoing coding efforts. Specifically, "[l]ate last month, Google updated the data being used to train Gemini in ..
Jul 24 · 15:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celcuity Inc. ("Celcuity" or "the Company") (NASDAQ:CELC). Investors who purchased Celcuity securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/CELC. Celcuity Investigation Details On July 14, 2026, Celcuity issued a press release announcing that it had secured U.S. Food and Drug Administration approval for its breast cancer therapy Revtorpyk (gedatolisib) and "anticipates commercial launch in late Q3 2026", representing a delayed launch timeline relative to analyst expectations. Commenting on ..
Jul 24 · 15:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pentair plc ("Pentair" or "the Company") (NYSE:PNR). Investors who purchased Pentair securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/PNR. Pentair Investigation Details On July 14, 2026, Pentair issued a press release announcing its preliminary second quarter 2026 financial results and revising its full year 2026 guidance. For the second quarter, Pentair reported that "[s]ales are expected to be approximately $930 million, down 17 percent versus previous guide of ..
Jul 24 · 15:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FirstSun Capital Bancorp ("FirstSun" or "the Company") (NASDAQ:FSUN). Investors who purchased FirstSun securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/FSUN. FirstSun Investigation Details On July 9, 2026, FirstSun disclosed that it now "expect[s] charge-offs to average loans to be in the high 50s range in basis points" and projected a $40-$41 million provision for credit losses and $42-$43 million in charge-offs, including a $22 million charge-off tied to ..
Jul 24 · 15:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AstraZeneca PLC ("AstraZeneca" or "the Company") (NYSE:AZN). Investors who purchased AstraZeneca securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/AZN. AstraZeneca Investigation Details On July 9, 2026, AstraZeneca disclosed that the late-stage Phase-3 CARDIO-TTransform trial of Wainua, an amyloid cardiomyopathy treatment developed in collaboration with Ionis Pharmaceuticals, did not meet its primary endpoint. Following this news, AstraZeneca's American Depositary Share ("ADS") price fell $10.79 per ADS, or 5.7%, to ..
Jul 24 · 15:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. ("Solstice" or "the Company") (NASDAQ:SOLS). Investors who purchased Solstice securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/SOLS. Solstice Investigation Details On July 6, 2026, Solstice issued a press release announcing an agreement to acquire Element Solutions ("Element") "in a cash-and-stock transaction valued at approximately $14.5 billion, including the assumption of net debt." Although Solstice's Chief Executive Officer described the "combined company [as] very well-positioned ..
Jul 24 · 15:01·PR-Inside
Finance · AI
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rackspace Technology, Inc. ("Rackspace" or "the Company") (NASDAQ:RXT). Investors who purchased Rackspace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/RXT. Rackspace Investigation Details On July 9, 2026, Rackspace released preliminary second-quarter 2026 financial results and lowered its 2026 outlook "[t]o account for [its] transition away from certain low-margin engagements that will be redeployed to [its] enterprise AI business." The Company now estimates revenue midpoint at $2.5B (versus prior ..
Jul 24 · 15:01·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Concentrix Corporation ("Concentrix" or "the Company") (NASDAQ:CNXC). Investors who purchased Concentrix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/CNXC. Concentrix Investigation Details On June 29, 2026, Concentrix reported its Q2 2026 financial results. The Company's results missed analyst consensus estimates, and it also slashed its full-year outlook. Following this news, Concentrix's stock price dropped the next day. What's Next for Concentrix Investors? If you are aware of any facts relating ..
Jul 24 · 15:01·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. ("Alignment" or "the Company") (NASDAQ:ALHC). Investors who purchased Alignment securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/ALHC. Alignment Investigation Details On July 8, 2026, Modern Healthcare reported that a former Alignment executive had filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation. Specifically, the lawsuit claims that Alignment deliberately misclassified routine operating expenses (such as ..
Jul 24 · 15:01·PR-Inside
AI
Backed by the governments of Benin, Kenya, Namibia, Nigeria and Togo, Africa Umoja AI builds on the momentum of the AI for Good Global Commission to advance trusted, inclusive AI in Africa, by Africa, for Africa. ABUJA, Nigeria, July 24, 2026 /PRNewswire/ -- The GSMA supports the Abuja...
Jul 24 · 15:01·mlpr-prnewswire-wire
Finance · Energy
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bloom Energy Corporation ("Bloom" or "the Company") (NYSE:BE). Investors who purchased Bloom securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/BE. Bloom Investigation Details On July 8, 2026, Hunterbrook published a report alleging, among other things, that despite the Company repeatedly claiming Bloom has "no China supply chain" and is "not dependent on China for scandium," (the rare earth at the core of each Bloom fuel cell) "Bloom is, ..
Jul 24 · 15:00·PR-Inside